Shares of Tilray (TLRY -5.00%) are down 16.7% this week as of Thursday's close, according to data provided by S&P Global Market Intelligence, after the cannabis products and alcoholic beverage company announced mixed quarterly results relative to analysts' expectations.

NASDAQ: TLRY

Tilray Brands
Today's Change
(-5.00%) -$0.10
Current Price
$1.90
 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 

Tilray's record quarter just wasn't enough

For its second quarter of fiscal year 2024, which ended Nov. 30, 2023, Tilray's revenue grew 34% year over year to $193.8 million, slightly below Wall Street's estimates for $195 million. On the bottom line, that translated to a non-GAAP(adjusted) net loss of $2.7 million, or roughly breakeven on a per-share basis, which handily beat expectations for a loss of $0.06 per share.

Within its top line, Cannabis revenue grew 35% to $67 million, beverage alcohol revenue climbed 117% to $47 million (helped in part by recent acquisitions), and distribution net revenue rose 12% to $67 million.

Tilray Chairman and CEO Irwin Simon was pleased with the quarter, calling the company "a major force at the forefront of innovation, disrupting the global CPG industry across medical and adult-use cannabis, wellness foods and snacks, and craft beverages."

What's next for Tilray investors?

Looking ahead to the rest of the fiscal year ending May 31, 2024, Tilray also reiterated its outlook for adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $68 million to $78 million (up 11% to 27% year over year). Management also continues to expect to achieve positive adjusted free cash flowfor the year.

MOTLEY FOOL RETURNS

Motley Fool Stock Advisor

Market-beating stocks from our flagship service.

STOCK ADVISOR RETURNS
552%
 
S&P 500 RETURNS
139%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 01/12/2024.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Join Stock Advisor 

In the end, Tilray's slight revenue shortfall notwithstanding, this was as solid a quarter as any investor could have hoped, given the current uncertain macroeconomic climate. I think long-term investors might do well to consider opening or adding to a position in Tilray at these prices.

Wondering Where to Invest $1,000 Right Now?

Before you put a single dollar into the stock market, we think you’ll want to hear this.

Our S&P/TSX market beating* Stock Advisor Canada team just released their top 10 starter stocks for 2023 that we believe could supercharge any portfolio.

Want to see what made our list? Get started with Stock Advisor Canada today to receive all 10 of our starter stocks, a fully stocked treasure trove of industry reports, two brand-new stock recommendations every month, and much more.

Click here to learn more.